Identification of cholera hotspots in Zambia: A spatiotemporal analysis of cholera data from 2008 to 2017.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
04 2020
Historique:
received: 15 06 2019
accepted: 17 03 2020
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 1 7 2020
Statut: epublish

Résumé

The global burden of cholera is increasing, with the majority (60%) of the cases occurring in sub-Saharan Africa. In Zambia, widespread cholera outbreaks have occurred since 1977, predominantly in the capital city of Lusaka. During both the 2016 and 2018 outbreaks, the Ministry of Health implemented cholera vaccination in addition to other preventative and control measures, to stop the spread and control the outbreak. Given the limitations in vaccine availability and the logistical support required for vaccination, oral cholera vaccine (OCV) is now recommended for use in the high risk areas ("hotspots") for cholera. Hence, the aim of this study was to identify areas with an increased risk of cholera in Zambia. Retrospective cholera case data from 2008 to 2017 was obtained from the Ministry of Health, Department of Public Health and Disease Surveillance. The Zambian Central Statistical Office provided district-level population data, socioeconomic and water, sanitation and hygiene (WaSH) indicators. To identify districts at high risk, we performed a discrete Poisson-based space-time scan statistic to account for variations in cholera risk across both space and time over a 10-year study period. A zero-inflated negative binomial regression model was employed to identify the district level risk factors for cholera. The risk map was generated by classifying the relative risk of cholera in each district, as obtained from the space-scan test statistic. In total, 34,950 cases of cholera were reported in Zambia between 2008 and 2017. Cholera cases varied spatially by year. During the study period, Lusaka District had the highest burden of cholera, with 29,080 reported cases. The space-time scan statistic identified 16 districts to be at a significantly higher risk of having cholera. The relative risk of having cholera in these districts was significantly higher and ranged from 1.25 to 78.87 times higher when compared to elsewhere in the country. Proximity to waterbodies was the only factor associated with the increased risk for cholera (P<0.05). This study provides a basis for the cholera elimination program in Zambia. Outside Lusaka, the majority of high risk districts identified were near the border with the DRC, Tanzania, Mozambique, and Zimbabwe. This suggests that cholera in Zambia may be linked to movement of people from neighboring areas of cholera endemicity. A collaborative intervention program implemented in concert with neighboring countries could be an effective strategy for elimination of cholera in Zambia, while also reducing rates at a regional level.

Identifiants

pubmed: 32294084
doi: 10.1371/journal.pntd.0008227
pii: PNTD-D-19-00964
pmc: PMC7159183
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0008227

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Stat Med. 2001 Jul 30;20(14):2183-204
pubmed: 11439429
PLoS Negl Trop Dis. 2017 Dec 28;11(12):e0006118
pubmed: 29284003
Lancet. 2016 Jan 2;387(10013):28
pubmed: 26766343
BMC Public Health. 2016 Jan 14;16:36
pubmed: 26762151
Emerg Infect Dis. 2008 May;14(5):798-800
pubmed: 18439365
Bull World Health Organ. 2018 Feb 1;96(2):86-93
pubmed: 29403111
PLoS Med. 2005 Mar;2(3):e59
pubmed: 15719066
Emerg Infect Dis. 2016 Feb;22(2):233-41
pubmed: 26811968
PLoS One. 2017 Aug 24;12(8):e0183100
pubmed: 28837645
Malawi Med J. 2012 Jun;24(2):29-33
pubmed: 23638267
PLoS Negl Trop Dis. 2015 Jan 08;9(1):e3440
pubmed: 25569505
Int J Epidemiol. 2017 Dec 1;46(6):2056-2066
pubmed: 29025064
PLoS Negl Trop Dis. 2015 Jun 04;9(6):e0003832
pubmed: 26043000

Auteurs

John Mwaba (J)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Amanda K Debes (AK)

Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States.

Patrick Shea (P)

Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States.

Victor Mukonka (V)

Zambia National Public Health Institute, Lusaka, Zambia.

Orbrie Chewe (O)

Zambia National Public Health Institute, Lusaka, Zambia.

Caroline Chisenga (C)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Michelo Simuyandi (M)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Geoffrey Kwenda (G)

University of Zambia, School of Health Sciences, Lusaka, Zambia.

David Sack (D)

Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States.

Roma Chilengi (R)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Mohammad Ali (M)

Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH